Accelrys is very pleased to announce the release of the latest version of Accelrys Discovery Studio 4.0, our most complete and integrated solution for both biologics and small molecules-based research.

Version 4.0 includes many new features and enhancements including:

• Simulations sciences
  • Faster robust support for ns-scale MD simulations
  • Improved simulations workflow
  • Faster & robust Explicit solvation builder
  • Enhanced Molecular Dynamics analysis tools

• Biologics research
  • New! Disulfide bond predictor
  • New! Multiple simultaneous mutations
  • Updated: Antibody database (Includes support to add your own antibody structures)
  • Updated: Antibody modeling workflows

• Small-molecules drug research
  • New! Non-bond interaction monitors (including the most extensive set of favourable, unfavourable and unsatisfied interactions)
  • Updated In-situ FBDD lead optimization
  • Updated In-situ FBDD core-hopping tools
  • Updated Find Activity Cliffs using MMPs

• Partner Science
  • CHARMm c37b2 (fully integrated charmm36 support)
  • NAMD v2.9 (New! NAMD is now included with Discovery Studio!)
  • MODELER 9v12
  • DMol3 version 6.1 SP2
  • VAMP version 10.0
  • Updated support for CCDC's GOLD

• Core/Platform
  • Significantly improved client memory management
  • Supports the latest Accelrys Enterprise Platform release (v9.1)

Learn how to accelerate molecular simulations for your drug discovery research, with Discovery Studio 4.0!  Register now for our live webinar series:

• Oct 22: What’s New in Discovery Studio 4.0
• Oct 29: Design Better Biologics with Improved Stability and Binding Affinity
• Nov 5:   Simplifying Molecular Simulations and Analysis with Discovery Studio ®
• Nov 12: Discovery Studio Non-Bond Analysis: Understanding Interactions

Note:  If you are looking for the 4.0 editions of our free Accelrys DS Visualizer and ActiveX Control, they will be released soon!

Best regards,

Adrian.

Snr Manager, Predictive Sciences Marketing, Life Sciences